Eli Lilly
4,389 hedge funds and large institutions have $713B invested in Eli Lilly in 2026 Q1 according to their latest regulatory filings, with 241 funds opening new positions, 1,955 increasing their positions, 1,704 reducing their positions, and 230 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 1,955 | Existing positions reduced: 1,704
5% more first-time investments, than exits
New positions opened: 241 | Existing positions closed: 230
0.93% less ownership
Funds ownership: 82.99% → 82.06% (-0.93%)
1% less funds holding
Funds holding: 4,449 → 4,389 (-60)
15% less capital invested
Capital invested by funds: $843B → $713B (-$130B)
22% less funds holding in top 10
Funds holding in top 10: 489 → 379 (-110)
29% less call options, than puts
Call options by funds: $9.52B | Put options by funds: $13.4B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$1.52B |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.23B |
| 3 |
JP Morgan Chase
New York
|
+$710M |
| 4 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$647M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$628M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$3.8B |
| 2 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$1.74B |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$931M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$828M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$789M |
LLY Hedge Fund Activity: Q1 2026 in Review
4,389 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2026, worth a combined $713B — down 15% from $843B a quarter earlier.
Buyers outnumbered sellers: 241 funds opened new LLY positions and 230 closed out — a net gain of 11 holders — while 1,955 added to existing stakes and 1,704 trimmed.
The largest buyer was Fifth Third Bancorp, adding an estimated $1.52B. The largest seller was Capital International Investors, cutting an estimated $3.8B.
- 4,389 institutional investors held Eli Lilly (LLY) as of Q1 2026, down from 4,449 in Q4 2025.
- Funds reported $713B of Eli Lilly stock for Q1 2026, down 15% quarter-over-quarter.
- 241 funds opened new Eli Lilly positions in Q1 2026 and 230 closed out, a net change of +11 holders.
- The largest Eli Lilly buyer in Q1 2026 was Fifth Third Bancorp, an estimated $1.52B added.
- The largest Eli Lilly seller in Q1 2026 was Capital International Investors, an estimated $3.8B sold.
Based on aggregated 13F filings for Q1 2026.